News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Research>M Stanley: HENGRUI PHARMA Forms USD15.2B Strategic Partnership with BMS to Accelerate Globalization
Morgan Stanley said that HENGRUI PHARMA (01276.HK) and Bristol-Myers Squibb Company (BMS) (BMY.US) announced a global strategic partnership covering 13 pre-clinical assets, with a ...
Reset
Send
The window will close in 5 seconds
<Research>M Stanley: HENGRUI PHARMA Forms USD15.2B Strategic Partnership with BMS to Accelerate Globalization
Close
Recommend
6
Positive
7
Negative
3
 
 

Morgan Stanley said that HENGRUI PHARMA (01276.HK)  +0.350 (+0.598%)    Short selling $30.98M; Ratio 20.027%   and Bristol-Myers Squibb Company (BMS) (BMY.US)      announced a global strategic partnership covering 13 pre-clinical assets, with a total deal value of USD15.2 billion. The transaction includes an upfront payment of USD600 million, combined annual payments of USD350 million for 2027-28, up to USD14.3 billion in milestone payments, and tiered sales-based royalties.

The broker believed this strategic collaboration, spanning multiple formats and asset modalities, further validates HENGRUI PHARMA's early-stage R&D platform and enhanced globalization capabilities. Beyond near-term cash proceeds, the reciprocal collaboration structure and co-development and co-commercialization could also accelerate HENGRUI PHARMA's globalization pace and generate commercial synergies in the China market for its expanding immunology portfolio.

Related News Citi Lists Latest H Shrs Buy Top Picks (Table)
Morgan Stanley maintained HENGRUI PHARMA as its top pick in China's healthcare sector, assigning an Overweight rating with a target price of HKD92 for its H shares.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-06-02 16:25.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

Auto-translated by AI
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.